Clinical Trials on Neoplasm, Breast in Hungary
Total 1433 results
-
GlaxoSmithKlineCompleted
-
National Institute of Oncology, HungaryUnknownInvasive Breast Cancer | in Situ Breast CancerHungary
-
National Institute of Oncology, HungaryCompleted
-
National Institute of Oncology, HungaryCompleted
-
National Institute of Oncology, HungaryNot yet recruiting
-
National Institute of Oncology, HungaryActive, not recruitingBreast Cancer | Radiation Toxicity | Side EffectsHungary
-
Central European Cooperative Oncology GroupTerminatedMetastatic Breast CancerHungary, Austria
-
Semmelweis UniversityRecruitingHER2-negative Breast CancerHungary
-
GlaxoSmithKlineWithdrawnNeoplasms, BreastHungary, Norway, Austria, Spain
-
Central European Cooperative Oncology GroupCompletedBreast CancerAustria, Hungary, Poland, Slovakia
-
AstraZenecaCompleted
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); Breast International GroupTerminatedBreast CancerSwitzerland, Italy, Hungary
-
Hoffmann-La RocheCompleted
-
PfizerHospira, now a wholly owned subsidiary of PfizerCompletedNon-metastatic Breast CancerHungary, Spain
-
ERYtech PharmaTerminatedTriple Negative Breast CancerSpain, Belgium, Hungary
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Patient SatisfactionHungary
-
University of Erlangen-Nürnberg Medical SchoolUnknownBreast CancerAustria, Germany, Hungary, Poland, Spain
-
Genzyme, a Sanofi CompanyCompletedAdvanced Breast CancerSouth Africa, Sweden, Hungary, Taiwan, Spain
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedMetastatic Breast CancerHungary
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Mastectomy; LymphedemaHungary
-
PfizerTerminatedBreast CancerUnited States, Belgium, Hungary, China, Hong Kong, Poland, Singapore
-
Hoffmann-La RocheCompleted
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Patient Satisfaction | Mastectomy; LymphedemaHungary
-
Eli Lilly and CompanyCompletedBreast CancerBrazil, Greece, Hungary, Peru, Poland, Spain, Venezuela
-
Bristol-Myers SquibbCompletedBreast CancerAustralia, Hungary, Canada, United Kingdom, Belgium
-
Eli Lilly and CompanyCompletedBreast CancerAustria, Czech Republic, Hungary, Poland, Romania, Russian Federation
-
Acrotech Biopharma Inc.CompletedBreast Cancer | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Human Mammary CarcinomaFrance, United States, Czechia, Hungary
-
AstraZenecaCompleted
-
Prestige Biopharma LimitedCompletedHER2 Positive Breast CancerSpain, Malaysia, Estonia, Hungary, Thailand, Belarus, Bulgaria, France, Georgia, Italy, Poland, Russian Federation, Ukraine
-
Carrick Therapeutics LimitedPfizerRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerSpain, United States, Turkey, Hungary
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSpain, Switzerland, Hungary, France, Italy, Peru, Portugal, Sweden
-
Spanish Breast Cancer Research GroupPfizer; AstraZenecaCompletedMetastatic Breast CancerSpain, Israel, Hungary, Austria
-
Institut de Recherches Internationales ServierBreast International GroupCompletedBreast CancerUnited Kingdom, Italy, France, Belgium, Australia, Canada, Germany, Hungary, Spain
-
AstraZenecaCompletedFGFR Inhibition, Pharmacokinetics, Biomarkers | ER+ Breast CancerCzech Republic, Italy, United Kingdom, Hungary, Germany, Romania, Belgium, France
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedBreast CancerSpain, Poland, Italy, Austria, Russian Federation, Slovakia, Hungary, Germany, Czech Republic, Estonia, Latvia
-
Immutep S.A.S.CompletedAdenocarcinoma Breast Stage IVNetherlands, United Kingdom, France, Belgium, Germany, Hungary, Poland
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSwitzerland, Australia, Slovenia, Italy, Sweden, Hungary, Israel, South Africa, New Zealand
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerBelgium, Turkey, Canada, Poland, Romania, Hungary, France, Czechia
-
MedSIRHoffmann-La RocheActive, not recruitingEarly Breast CancerSpain, Italy, Germany, Bulgaria, Hungary
-
Queen Mary University of LondonAstraZeneca; Cancer Research UKUnknownMetastatic Breast CancerKorea, Republic of, United Kingdom, Hungary, Georgia, France, Romania
-
PfizerTerminatedTriple Negative Breast NeoplasmsSpain, United Kingdom, United States, Italy, Hungary, Poland
-
PfizerTerminatedAdvanced Breast CancerUnited States, Hungary, Spain, Belgium, China, Hong Kong, Australia, Poland, Canada, India, South Africa
-
Hoffmann-La RocheCompletedBreast CancerEstonia, Hungary, Turkey, Israel, Slovakia, Bulgaria, Lithuania, Macedonia, The Former Yugoslav Republic of
-
ETOP IBCSG Partners FoundationTerminatedBreast CancerItaly, Australia, Belgium, Switzerland, Slovenia, Hungary, Sweden, New Zealand, Romania
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerUnited States, France, Canada, Brazil, Poland, Germany, Portugal, Spain, Sweden, Slovakia, Czech Republic, Uruguay, Argentina, Egypt, Hungary, Israel, South Africa, Austria, Greece, United Kingdom
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand
-
University Hospital, Basel, SwitzerlandETOP IBCSG Partners Foundation; Austrian Breast Cancer Study GroupRecruitingNode-positive Breast CancerGreece, Switzerland, Hungary, Austria, Germany, Italy, Lithuania, Argentina, Croatia
-
ETOP IBCSG Partners FoundationHoffmann-La RocheRecruitingBreast CancerIreland, Italy, Germany, Spain, Hungary, France, Sweden, Switzerland
-
AstraZenecaCompletedBreast CancerSweden, Czech Republic, France, Spain, United Kingdom, Hungary, Portugal